drugset / Trial / NCT00376181
Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of pioglitazone-azilsartan, once daily (QD), in subjects with type 2 diabetes mellitus with poor glycemic control.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan | Unknown | 20 mg | Oral |
| Subject | Azilsartan | Unknown | 40 mg | Oral |
| Comparator | Pioglitazone | Small molecule | 45 mg | Oral |